Background: Microvascular free flap techniques have improved over the past two decades such that flap failure rates have dropped to under 3 percent in most large series of high-volume centers. However, despite technical and patientselection advances, some components of free flap failure might be attributable to undiagnosed patient factors. Methods: In this clinicopathologic conference article, the authors present four patients with major free flap microvascular complications who were later diagnosed with multiple risk factors for hypercoagulability and biochemical abnormalities, and present the characteristic associated findings. Results: Previously undiagnosed hypercoagulability was present in four patients with major free flap microvascular complications. Hematologic consultation and laboratory investigation revealed the biochemical abnormalities. Conclusions: In certain patients undergoing microvascular free flap reconstruction, undiagnosed hypercoagulability risk factors can be a source of free flap failure that is independent of patient selection or technical factors. Diagnosis, management, patient counseling, and initiation of deep venous thromboembolism prophylaxis measures are critical clinical components of care of these patients. (Plast.
M
icrosurgical reconstruction has become progressively more successful. From the early microvascular flaps to current perforator flaps, the success rate has increased from 63 percent to 98.8 percent at centers of excellence. [1] [2] [3] [4] [5] Despite greater experience, improved technology, and development of anastomotic devices, the average failure rate has not dropped below 1 to 3 percent. The failure rate falls with superspecialization to one flap (deep inferior epigastric perforator flap), improved patient selection, and consistency of surgeon, yet it is not zero.
Although the vast majority of studies of free flap failure allude to technical causes of thrombosis, there are some cases in which the patient is the contributing factor to flap failure. 3,6 -9 One of the hidden contributing factors is undiagnosed coagulopathy. 9, 10 We present four cases in which multiple free flap failures were a direct result of underlying hidden patient predisposition to developing hypercoagulability complications. We discuss the cases, findings, and pathophysiology to illustrate this process. The most problematic aspect is that the first presentation of coagulopathy might be microvascular complications of the free flap. We also discuss laboratory evaluation of the patient and long-term implications for deep venous thrombosis prophylaxis.
The coagulopathies that are represented in our case series range from relatively common to rare. Many of these coagulopathies are described by their genetic mutation and genetic load (homozygous versus heterozygous). Of critical importance is the concept that, as in much of medicine, flap failure is often multifactorial such that underlying coagulopathy might serve to either cause or predispose to microvascular anastomotic thrombosis.
CASE REPORTS Case 1
A 43-year-old white woman with a previous wide resection of the cheek and orbital exenteration for lacrimal gland tumor presented with an ethmoid sinus fistula. Sinusectomy and wider excision of the orbit required soft-tissue filling. A superficial inferior epigastric artery free flap to the superficial temporal artery and vein anastomoses was attempted, which resulted in immediate intraoperative difficulties with an arterial thrombus. This failure was attributed initially to recipient vessel spasm and donor vessel diameter. At the same operation, a salvage deep inferior epigastric artery perforator flap with pedicle length adequate to reach the retromandibular external carotid artery was difficult to infuse, requiring multiple arterial anastomoses and tissue plasminogen activator flush and heparin drip. The arterial anastomosis failed 12 hours later. Delayed reconstruction was performed using free tissue grafts and artificial dermal substitute. A postoperative hematologic workup revealed elevated plasminogen activator inhibitor-1 activity (79 percent; normal, 4 to 43 percent), protein S activity deficiency (57 percent; normal, 65 to 140 percent), elevated factor VIII activity (175 percent; normal, 50 to 150 percent), and elevated antiphosphatidyl immunoglobulin G and immunoglobulin M antibodies (G-phospholipid, 31 U/ml; M-phospholipid 26 U/ml; normal, Ͻ11 and Ͻ25 U/ml, respectively). Furthermore, gene testing by means of polymerase chain reaction techniques revealed that she was compound-heterozygous for the C677T and A1298C polymorphisms for the MTHFR gene mutation and was heterozygous for the R506Q polymorphism for the factor V Leiden gene.
Case 2
A 38-year-old white woman with right breast disseminated carcinoma in situ underwent bilateral mastectomy with immediate reconstruction by means of bilateral free transverse rectus abdominis musculocutaneus flap surgery. The patient had a 17-pack-year smoking history and a BRCA1 mutation. Attempted bilateral muscle-sparing transverse rectus abdominis musculocutaneus flaps to the thoracodorsal arteries were attempted. Each flap anastomosis remained patent for approximately 30 minutes and then clotted. Attempted revision to the internal mammary artery vessels with papaverine administration and adventiectomy were attempted, but the flap failed despite these efforts. A total of six anastomoses were attempted. Throughout the case, the anastomosed vessels appeared cloudy and flaccid. The flaps were discarded and the breast flaps were closed primarily.
A hematologic workup revealed that the patient carried a PAI-1 gene mutation positive for one copy of the 4G allele, had protein S activity deficiency (54 percent; normal, 65 to 140 percent), and was a heterozygote for the factor V Leiden R506Q gene mutation.
Case 3
A 29-year-old white woman with left buccal sulcus carcinoma underwent wide local excision with radial forearm free flap reconstruction. Surgery was complicated by a return to the operating room for intermittent flow interruption and release of the tunnel for the vessels. The patient also developed a subsequent deep venous thrombosis from a peripherally inserted central catheter line.
Six months after a recurrence, a through-and-through defect on the cheek was reconstructed with a second radial forearm free flap to the superficial temporal vessels. Multiple arterial thromboses were encountered and the flap was finally wellvascularized until it went into spasm after an intraoperative dose of Neo-Synephrine (Bayer HealthCare, Leverkusen, Germany). Attempted salvage with a deep inferior epigastric artery perforator flap experienced significant inflow issues and was left lying on the cheek, as inset occluded flow (Fig. 1) .
A postoperative hematologic workup revealed that the patient was homozygous positive for the C677T polymorphism for the MTHFR gene and had elevated levels of factor VIII activity (214 percent; normal, 50 to 150 percent). She was also found to be hypothyroid, with a thyroid-stimulating factor level of 23 mIU/liter (normal, 0.23 to 5.6 mIU/liter) and a free thyroxine level of 0.51 ng/dl (normal, 0.58 to 1.64 ng/dl).
Case 4
A 42-year-old white woman with recurrent squamous cell cancer of the anterior floor of the mouth underwent composite resection including partial mandibulectomy. The patient had previously received irradiation to the site and had an extensive history of alcohol and tobacco use.
The oral defect was reconstructed using an immediate radial forearm free flap that was complicated by arterial clot that was cleared by thrombectomy in the same operative setting. Of note, the patient had had an arterial line placed previously in the donor extremity, and despite a negative Allen test preoperatively, the extremity donor site became ischemic and required a radial artery reconstruction using a vein graft in the same surgical setting.
The postoperative course was complicated by recurrent thrombosis of the free flap artery at the site of the previous arterial line, which resulted in loss of the radial forearm free flap (Fig. 2) . The defect was then reconstructed in delayed fashion using an anterolateral thigh free flap, which developed postoperative necrosis of the distal half, although sufficient tissue survived to provide the needed soft-tissue coverage. In addition, the patient developed gangrene of one toe during her hospital stay, distal to the dorsalis pedis artery, which had been cannulated with an arterial catheter (Fig. 3) .
Consultation with the hematology service and a hypercoagulable workup revealed that the patient was compound heterozygous for the C677T/A1298C polymorphisms for the MTHFR gene mutation. After the first failed free flap, the patient was fully heparinized (goal partial thromboplastin time, 60 to 80 seconds) until final flap survival was ascertained.
Intraoperative Findings
The intraoperative experience with these cases was similar. The flaps initially flashed up on the first anastomosis after 
DISCUSSION
Microvascular free flap failure can be categorized into technical and patient-related factors. Of the latter group, previously diagnosed contributions have been stratified using advanced diagnostic paradigms, and patient selection criteria have been refined to optimize flap success rates. [11] [12] [13] [14] [15] In contrast, our current series highlights patient factors that are not routinely or efficiently detected that appear to have led directly to failure in these four patients. All patients had arterial anastomosis failures that were essentially lost on the operating table, or were taken off the table as desperate salvage cases with little chance of success. These patients then required an alternative reconstructive option for defect closure.
In aggregate, these four patients had five total free flap losses, two partial flap losses, and one salvaged thrombus. These four patients represent 30 percent of the flap failures in 325 free flaps performed by the senior author (S.P.D.) in over a decade. In addition, they also had one deep vein thrombosis and two limb ischemic events.
Hypercoagulable events resulting from genetic and acquired causes are not rare in the general population. The most common genetic hypercoagulable states include mutations of coagulation factors V (factor V Leiden gene R506Q mutation) and II (prothrombin G20210A mutation); mutations of the methylene tetrahydrofolate reductase gene (C677T and A1298C polymorphisms), leading to hyperhomocysteinemia; and mutations of the plasminogen activator inhibitor-type 1 gene (4G/5G alleles), which modulates endogenous fibrinolytic activity. Other patients without a genetic predisposition can develop diseases, such as malignancy or autoimmune disorders (including antiphospholipid antibody syndrome), that produce a hypercoagulable state. Furthermore, certain medications can promote a procoagulopathic state. The hypercoagulable patient can be asymptomatic and undiagnosed, and in fact we probably operate on many patients whose hypercoagulable state is not known, suspected, or significant. A thorough fam- 
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ily medical history is probably the most valuable tool with which to reveal a genetic suspicion for hypercoagulability.
However, under certain circumstances, an undiagnosed hypercoagulopathy can become clinically relevant. In particular, the patients in our series were all undergoing microvascular free flap surgery following resection of head and neck squamous cell carcinoma or breast ductal carcinoma in situ. The combination of an underlying genetic predisposition to hypercoagulability, plus significant operative time (contributing an element of stasis), plus the presence of a squamous cell carcinoma or ductal carcinoma in situ (and their potential prothrombotic contribution), and the effects of inflammation on activation of coagulation, all coalesce into a clinical scenario where microvascular anastomosis becomes unfeasible. In our examples, these hypercoagulable events manifested themselves following many hours in the operating room, during which multiple microanastomoses were unsuccessfully attempted. Given the significant morbidity of extended operative time and microvascular reattempts, we suggest that certain intraoperative findings should raise the suspicion for a hypercoagulable state, and abandonment of microvascular repair be considered pending a thorough hematologic workup (Table 1) . This scenario again emphasizes the value of a thorough preoperative family medical history.
Multiple reports have been presented in the literature of hypercoagulopathic events contributing to reconstructive complications. In particular, head and neck reconstruction cases have been noted to have free flap failure in patients with underlying coagulopathies. 16, 17 Similarly, undiagnosed hypercoagulopathy has been implicated in free flap failures in reconstruction of the breast, extremities, and torso. 6, 9, 10, 18, 19 Other hematologic disorders, and even medications that mediate hypercoagulability, have also been insinuated as the causes of microvascular anastomotic failure. 20, 21 Indeed, coagulopathy and hematologic disorders in general have been cited as factors in free flap outcomes but have been regarded as complex, difficult to assess preoperatively, and of variable significance. 11, 14, 15, 22 Unfortunately, no routine, inexpensive, specific screening test predicts for the development of hypercoagulopathy-related perioperative complications. Screening for deep venous thrombosis risk and measurement of prothrombin time and partial thromboplastin time will identify some patients with possible coagulopathies; however, the majority of hypercoagulable patients are generally not detected preoperatively. 23 Once a hypercoagulable state is suspected-as in multiple microvessel anastomotic failures-a series of hematologic studies should be performed, often in consultation with the hematology service. The standard battery of tests include testing for antithrombin III deficiency, protein C and S deficiency, factor V Leiden, and homocysteine levels ( Table 2 ). In addition, several endocrine conditions could aggravate the hypercoagulable state, and therefore thyroid status (thyroid-stimulating hormone, free thyroxine) and adrenal function (free AM cortisone level, cortisone-stimulating test) should also be considered. Research tools that measure endogenous thrombin generation or global clot formation (such as those that use the thromboelastogram or its variants) might be useful in future development of effective screening tests.
Management of these patients changes once a diagnosis of a hypercoagulable state is established. First, the operative defect should be temporized using dressing changes until more definitive reconstruction can be safely performed. Second, immediate perioperative anticoagulation needs to be initiated, as the hypercoagulable state places the The plastic surgical literature has only several case reports of microvascular free flaps complicated by hypercoagulable states; yet if these conditions are present in up to 10 percent of the population, why are reports of these complications so scarce? The main reason is that microsurgical reconstruction, as in our institution, is becoming significantly more aggressive. The patients in this series all had locally advanced squamous cell carcinoma of the head and neck or breast adenocarcinoma. Most of the patients presented as recurrences, with preoperative irradiation to this site. All of the patients had significant tobacco and/or alcohol comorbidity, with nutritional deficiency. Every patient had surgical extirpation of the tumor in the same surgical setting as the initial microsurgical reconstruction, necessitating operative times in excess of 10 hours and intraoperative tumor manipulation. Finally, these patients also had at least one genetic hypercoagulable mutation; some patients had up to three separate mutations. Hypercoagulable events are often a clinical reflection of synergistic genetic abnormality with environmental conditions, and this synergy is exemplified in this patient population. We suspect that as the indications for free flap reconstruction continue to expand, this scenario will become increasingly recognized.
More than other malignancies, squamous cell carcinoma appears to have particular prothrombotic effects. It is noteworthy that three of the patients in this series had a locally advanced (often recurrent) squamous cell carcinoma, with tumor manipulation and extirpation immediately preceding the initial microvascular attempt. The prothrombotic, coagulopathic effect of squamous cell carcinoma, and the potential for aggravating the condition with surgical manipulation, could have had an effect on the coagulopathies of the patients in this case series.
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CONCLUSIONS
Patients with multiple coagulopathic abnormalities that have free flap failure should probably have a hematology consultation that includes a thorough coagulopathic workup. The hematologist, ideally with the plastic surgeon, should then counsel the patient as to his or her condition and the associated risks. Importantly, the patient should be advised on the use of prophylaxis for deep venous thrombosis and pulmonary embolus during future surgical procedures, prolonged immobilization, long car rides, and plane flights.
